Estrogen and Its Receptors in Cancer

被引:177
作者
Chen, George G. [1 ]
Zeng, Qiang [1 ]
Tse, Gary M. K. [2 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China
关键词
estrogen; estrogen receptor; cancer;
D O I
10.1002/med.20131
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The involvement of estrogen and its receptors in the development of cancer has been known for years. However, the exact mechanism responsible is far from clear. The estrogen-mediated carcinogenic process is complicated by recent findings, which reveal that estrogens have multiple functions in cells, which can be either adverse or beneficial, and that the effects of estrogen may be cell-type or organ dependent. The estrogenic effect may be also greatly influenced by the state of two estrogen receptors, ER alpha and ER beta. This review will discuss the role and function of estrogens and its receptors in cancers of three categories: (1) Breast cancer and gynecologic cancers, (2) Cancers of endocrine organs, (3) Lung cancer and cancers of digestive system. We will also review some novel treatments aiming to interfere with relevant pathways mediated by estrogens and its receptors. (C) 2008 Wiley Periodicals, Inc. Med Res Rev, 28, No. 6, 954-974, 2008
引用
收藏
页码:954 / 974
页数:21
相关论文
共 164 条
[1]   Estrogen and colon cancer: current issues [J].
Al-Azzawi, F ;
Wahab, M .
CLIMACTERIC, 2002, 5 (01) :3-14
[2]   Overexpression of estrogen receptor-α in the endometrial carcinoma cell line Ishikawa:: inhibition of growth and angiogenic factors [J].
Ali, SH ;
O'Donnell, AL ;
Mohamed, S ;
Mousa, S ;
Dandona, P .
GYNECOLOGIC ONCOLOGY, 2004, 95 (03) :637-645
[3]   Estrogen receptor β mRNA in colon cancer cells:: Growth effects of estrogen and genistein [J].
Arai, N ;
Ström, A ;
Rafter, JJ ;
Gustafsson, JÅ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (02) :425-431
[4]  
Arain SA, 2003, SAUDI MED J, V24, P174
[5]  
Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001
[6]   Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene [J].
Au, William W. ;
Abdou-Salama, Salama ;
Al-Hendy, Ayman .
GYNECOLOGIC ONCOLOGY, 2007, 104 (02) :276-280
[7]   Expression of aromatase and estrogen receptors in human adrenocortical tumors [J].
Barzon, Luisa ;
Masi, Giulia ;
Pacenti, Monia ;
Trevisan, Marta ;
Fallo, Francesco ;
Remo, Andrea ;
Martignoni, Guido ;
Montanaro, Daniela ;
Pezzi, Vincenzo ;
Palu, Giorgio .
VIRCHOWS ARCHIV, 2008, 452 (02) :181-191
[8]   Estrogen receptor modulators and down regulators - Optimal use in postmenopausal women with breast cancer [J].
Baumann, Christa K. ;
Castiglione-Gertsch, Monica .
DRUGS, 2007, 67 (16) :2335-2353
[9]   Loss of tumourigenicity of stably ERβ-transfected MCF-7 breast cancer cells [J].
Behrens, D. ;
Gill, J. H. ;
Fichtner, I. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2007, 274 (1-2) :19-29
[10]   Prognostic effect of estrogen receptor status across age in primary breast cancer [J].
Bentzon, Niels ;
Duering, Maria ;
Rasmussen, Birgitte Bruun ;
Mouridsen, Henning ;
Kroman, Niels .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (05) :1089-1094